UIA
VMD icon

Ulland Investment Advisors’s Viemed Healthcare VMD Stock Holding History

Ulland Investment Advisors’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$325K Sell
28,545
-33,340
-54% -$330K 0.24% 66
2026
Q1 		$570K Sell
61,885
-23,610
-28% -$196K 0.49% 39
2025
Q4 		$635K Buy
85,495
+12,400
+17% +$85K 0.51% 36
2025
Q3 		$496K Buy
73,095
+42,940
+142% +$291K 0.37% 43
2025
Q2 		$208K Buy
30,155
+14,595
+94% +$99.1K 0.16% 59
2025
Q1 		$113K Sell
15,560
-4,000
-20% -$31.4K 0.09% 78
2024
Q4 		$157K Sell
19,560
-5,850
-23% -$50.8K 0.1% 64
2024
Q3 		$186K Sell
25,410
-7,830
-24% -$55.9K 0.14% 60
2024
Q2 		$218K Buy
33,240
+10,790
+48% +$81.3K 0.15% 58
2024
Q1 		$212K Buy
22,450
+1,775
+9% +$15.2K 0.17% 58
2023
Q4 		$162K Buy
20,675
+8,050
+64% +$58.4K 0.16% 58
2023
Q3 		$85K Buy
+12,625
New +$103K 0.09% 81

Other funds holding VMD

PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
SIM
SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
BFA
Brendel Financial Advisors Hanover, New Hampshire $216M AUM 38.85% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
B
Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return
VCM
Violich Capital Management San Francisco, California $919M AUM 40.7% 1-Year Est. Return

Ulland Investment Advisors's VMD Position: Q2 2026 in Review

Ulland Investment Advisors reduced its Viemed Healthcare (VMD) stake by 54% in Q2 2026, selling an estimated $330K and leaving 28,545 shares worth $325K. The position accounts for 0.24% of the portfolio, ranked #66.

Ulland Investment Advisors first reported a position in VMD in Q3 2023 and has held it in 12 quarters since. The position peaked at $635K in Q4 2025. 38 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Ulland Investment Advisors held 28,545 shares of Viemed Healthcare worth $325K as of Q2 2026.
  • Ulland Investment Advisors sold 33,340 Viemed Healthcare shares in Q2 2026, an estimated $330K.
  • Viemed Healthcare made up 0.24% of Ulland Investment Advisors's portfolio in Q2 2026, its #66 holding.
  • Ulland Investment Advisors first reported a position in Viemed Healthcare in Q3 2023 and has held it in 12 quarters since.
  • Ulland Investment Advisors's Viemed Healthcare position peaked at $635K in Q4 2025.
  • 38 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Ulland Investment Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.